Market Reports /
by Peter Milios -
A year ago
02 May 2023 - Following the Reserve Bank's decision to raise the cash rate to 3.85 per cent, the S&P/ASX 200 closed 0.92 per cent lower at 7,267.40, with losses exceeding 1 per cen…
Market Reports /
by Peter Milios -
A year ago
02 May 2023 - At noon, the S&P/ASX 200 is 0.22 per cent lower at 7,318.50, due to weakness in the industrials and consumer staples sectors. Qantas shares (ASX:QAN) were among the d…
Market Reports /
by Peter Milios -
A year ago
21 Mar 2023 - The sharemarket had a positive day on Tuesday, finishing 0.82 per cent higher at 6,955.40, with the financials sector leading the way with a 1.2 per cent gain.
Market Reports /
by Peter Milios -
A year ago
21 Mar 2023 - According to UBS analysts, peak food inflation at Australian supermarkets Coles and Woolworths likely occurred during the December 2022 Christmas shopping period, rea…
Market Reports /
by Peter Milios -
A year ago
15 Mar 2023 - The Australian stock market experienced a 0.89 per cent increase, reaching 7068.9 points, mainly due to growth in the technology industry.
Market Reports /
by Peter Milios -
A year ago
15 Mar 2023 - The Australian stock market has recovered following encouraging performance in the United States, with the majority of sectors experiencing gains.
Company News /
by Rachael Jones -
6 years ago
13 Jul 2018 - Medical cannabis developer MGC Pharmaceuticals (ASX:MXC) has secured a Manufacturing License for its European GMP cannabis production facility.
Company News /
by Anna Napoli -
6 years ago
12 Jun 2018 - Medicinal cannabis company, MGC Pharma (ASX:MXC) has announced that luxury UK retailer Harvey Nichols will stock its MGC Derma and Derma Plus Cosmetics lines.
Company News /
by Anna Napoli -
6 years ago
21 May 2018 - MGC Pharmaceuticals (ASX:MXC) says the legalization of medicinal cannabis in Malta means it can obtain a formal contract for the production and cultivation of the pla…
Company News /
by Kathy Skantzos -
6 years ago
22 Jan 2018 - Medical cannabis company MGC Pharmaceuticals’ European subsidiary MGC Derma (ASX:MXC) signs a sales and distribution agreement with UK-based online beauty store Cult …
Market Reports /
by Jessica Ellerm -
6 years ago
04 Jan 2018 - WAM Capital Limited (ASX:WAM) withdraws its proposed takeover bid for Molopo Energy Limited (ASX:MPO) as a result of a ‘no material transactions’ condition being trig…
Company News /
by Kathy Skantzos -
6 years ago
04 Jan 2018 - Medical cannabis biopharma company MGC Pharmaceuticals $MXC has launched its first #DermaPlus product. #ASX #ausbiz
Company News /
by Jessica Amir -
7 years ago
02 May 2017 - MGC Pharmaceuticals Limited (ASX:MXC) announces it has signed a landmark agreement with the Royal Melbourne Institute of Technology (RMIT) to collaborate on research …
Company News /
by David Chau -
8 years ago
13 Jul 2016 - MGC Pharmaceuticals Ltd (ASX:MXC) begins stakeholder consultation about using medical cannabis to treat children with severe epilepsy, and appoints Israeli pediatric …
Company News /
by David Chau -
8 years ago
25 May 2016 - MGC Pharmaceuticals Ltd (ASX:MXC) receives FDA approval to sell for cannabis-based cosmetics in the US.